Physical activity associated with less chemo-induced peripheral neuropathy
the ONA take:
Meeting the physical activity guideline was associated with less chemotherapy-induced peripheral neuropathy (CIPN)-like symptoms and a higher health-related quality of life (HRQoL) regardless of treatment with chemotherapy among colorectal cancer survivors, a new study published in the Journal of Cancer Survivorship: Research and Practice has shown.
For the study, researchers in the Netherlands sought to investigate whether there is an association between physical activity, CIPN, and HRQoL among colorectal cancer survivors.
Researchers analyzed data from a Dutch prospective population-based survey among colorectal cancer survivors diagnosed between 2000 and 2009.
Of those, 83% completed the the EORTC QLQ-C30 and the EORTC QLQ-CIPN20 questionnaires. Of those, 31% were treated with chemotherapy.
Results showed that treatment with chemotherapy was associated with a higher number of patients reporting CIPN symptoms regardless of physical activity.
Researchers found that patients treated with chemotherapy who did not complete 150 minutes of moderate to vigorous physical activity a week experienced more CIPN. The study also showed that patients not treated with chemotherapy reported CIPN-like symptoms, especially when they did not complete the 150 minutes/week of exercise.
The findings suggest that health care professionals and colorectal cancer survivors should be aware of the importance of physical activity.
Meeting the physical activity guideline associated with less chemotherapy-induced peripheral neuropathy in colorectal cancer survivors.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|